16+
Major trials tracked
Cardiometabolic & renal · Live ClinicalTrials.gov data
Dapagliflozin (Farxiga) clinical trial pipeline
The timeline below tracks the 16 largest phase 2–4 dapagliflozin trials on ClinicalTrials.gov by enrolment, 3 of them actively recruiting. The next phase 3 primary completion among them is expected Aug 2026. Refreshed daily — add up to four competitors to compare pipelines side by side.
10
Phase 3 trials
3
Actively recruiting
Aug 2026
Next phase 3 primary completion
7,336
Participants across trials
AstraZeneca
Lead sponsor by trial count
dapagliflozin (16)6 active2007–2032
dapagliflozin
'07
'09
'11
'13
'15
'17
'19
'21
'23
'25
'27
'29
'31
dapagliflozin
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin AloneP3
Dapagliflozin DPPIV Inhibitor add-on StudyP3
Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 DiabetesP2
Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and SulfonylureaP3
Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 DiabetesP3
Phase III Insulin Add-On Asia Regional Program - STP3
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years OldP3
D3DOSAP3
Effect of Dapagliflozin on Renal Outcomes and Bone Mineral Disease in Non-diabetic Chronic Kidney Disease PatientsP4
ACHIEVE-2P3
SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes MellitusP4
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in BangladeshP4
STAMI-BASP4
THP-001-031P3
SLGT2i for Neuroprotection in Patients With Acute Ischemic StrokeP3
A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus and High Body Mass Index (BMI)P4
Upcoming readouts
4 ahead · dapagliflozin
Select a trial to load its full ClinicalTrials.gov record.
Key dapagliflozin trials
Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Each links to its full ClinicalTrials.gov record.
| Trial | Title | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT06562582 | STAMI-BAS — STunning in Acute Myocardial Infarction - BAS | Phase 4 | Recruiting | Dec 2027 |
| NCT06364930 | SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus | Phase 4 | Recruiting | Oct 2030 |
| NCT06449235 | Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh | Phase 4 | Not yet recruiting | Apr 2025 |
| NCT07311551 | A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients W… | Phase 4 | Not yet recruiting | Dec 2026 |
| NCT05735197 | Effect of Dapagliflozin on Renal Outcomes and Bone Mineral Disease in Non-diabetic Chronic Kidney Disease Pati… | Phase 4 | Completed | Aug 2023 |
| NCT06647745 | THP-001-031 — A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy a… | Phase 3 | Recruiting | Jun 2026 |
| NCT07105917 | SLGT2i for Neuroprotection in Patients With Acute Ischemic Stroke | Phase 3 | Not yet recruiting | Aug 2026 |
| NCT00528879 | A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled o… | Phase 3 | Completed | Nov 2008 |
| NCT00984867 | Dapagliflozin DPPIV Inhibitor add-on Study | Phase 3 | Completed | Mar 2011 |
| NCT01392677 | Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycae… | Phase 3 | Completed | Jan 2013 |
| NCT01619059 | Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes | Phase 3 | Completed | Jun 2014 |
| NCT02096705 | Phase III Insulin Add-On Asia Regional Program - ST | Phase 3 | Completed | Jan 2016 |
Related drug pipelines
FAQ
- How many clinical trials are running for dapagliflozin?
- ClinicalTrials.gov lists more than 16 phase 2–4 dapagliflozin trials. This page tracks the 16 largest by enrolment: 1 phase 2, 10 phase 3, and 5 phase 4 among them, with 3 actively recruiting. Updated daily.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare dapagliflozin against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist
Be the first to access ComplyRx
We'll let you know as soon as your spot opens to use ComplyRx.
By joining, you agree to our Privacy Policy.